BOOK
Evidence-Based Procedures in Facial Plastic Surgery, An Issue of Facial Plastic Surgery Clinics of North America, E-Book
(2015)
Additional Information
Book Details
Abstract
Evidence base in 2015 remains a subject of controversy for surgeons related to its application in surgery that cannot be approached as it is in medical evidence. Academic surgeons acknowledge that evidence base is necessary and private practitioners know it is woven into the fabric of their practice. Dr. Lisa Ishii and Dr. Travis Tollefson, editors of this publication, are at the forefront of clinical use of and research into evidence based surgery. The Oxford Centre system of evidence is used for this issue. Currently, evidence is dominant in the reconstructive aspect, moreso than the cosmetic aspect; as such, this resource focuses on the nerve and microvascular procedures. Topics include Facial vascular anomalies, Cleft lip and palate; Trauma; Facial reanimation; System reviews and metanalyses; and Skin care, Laser treatments; and Rhinoplasty. Audience for this resource is facial plastic surgeons, otolaryngologists, plastic surgeons, laser therapists, dermatologists, and skin researchers.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Evidence-Based Procedures in Facial Plastic Surgery\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| Contents | v | ||
| Facial Plastic Surgery Clinics Of North America\r | viii | ||
| Preface\r | ix | ||
| Systematic Review and Meta-Analysis in Facial Plastic Surgery | 273 | ||
| Key points | 273 | ||
| Introduction | 273 | ||
| What is a systematic review | 274 | ||
| How to conduct a systematic review | 274 | ||
| Defining the Research Question | 274 | ||
| Developing a Search Strategy | 274 | ||
| Identifying the Evidence | 274 | ||
| Evaluating Quality of Evidence and Bias | 275 | ||
| What is a meta-analysis? | 275 | ||
| How to conduct a meta-analysis | 277 | ||
| Standardizing the Results | 277 | ||
| Evaluating Heterogeneity | 277 | ||
| Synthesizing a Summary | 277 | ||
| Evaluating Robustness (Sensitivity Analysis) | 281 | ||
| Summary | 282 | ||
| References | 282 | ||
| Skin Care | 285 | ||
| Key points | 285 | ||
| Sunscreen | 285 | ||
| Retinoids | 286 | ||
| Alpha hydroxy acids | 289 | ||
| Antioxidants | 289 | ||
| Vitamin C | 289 | ||
| Vitamin E | 292 | ||
| Growth factors and peptides | 294 | ||
| Summary | 294 | ||
| References | 294 | ||
| Evidence-Based Medicine in Laser Medicine for Facial Plastic Surgery | 297 | ||
| Key points | 297 | ||
| Introduction | 297 | ||
| Non-invasive technologies | 298 | ||
| Intense Pulsed Light and Broad Band Light | 298 | ||
| Noninvasive Skin Tightening Devices | 299 | ||
| Ablative technologies | 301 | ||
| References | 302 | ||
| Evidence-Based Medicine | 303 | ||
| Key points | 303 | ||
| Introduction | 303 | ||
| Functional rhinoplasty | 304 | ||
| Outcome Evaluation in Functional Rhinoplasty | 304 | ||
| Objective anatomic measures | 304 | ||
| Objective physiologic measures | 305 | ||
| Patient-reported outcome measures | 305 | ||
| Clinician-derived measures | 305 | ||
| Discordance of objective and subjective outcome measures | 306 | ||
| Aesthetic rhinoplasty | 306 | ||
| Patient-Reported Outcome Measures | 306 | ||
| Objective Measures | 306 | ||
| Surgical techniques | 307 | ||
| Septum | 307 | ||
| Inferior Turbinates | 309 | ||
| Internal Nasal Valve | 309 | ||
| Lateral Wall | 309 | ||
| Summary | 310 | ||
| References | 310 | ||
| An Evidence-Based Approach to Facial Reanimation | 313 | ||
| Key points | 313 | ||
| Introduction/overview | 313 | ||
| Therapeutic options and surgical techniques | 313 | ||
| Clinical outcomes | 316 | ||
| Clinical evidence | 316 | ||
| Corneal Protection in Flaccid Facial Palsy | 316 | ||
| Pharmaceutical Therapy | 316 | ||
| Surgical Exploration and Decompression in Acute Flaccid Facial Palsy | 319 | ||
| Observation and Timing of Interventions | 321 | ||
| Neurorrhaphy | 322 | ||
| Physiotherapy | 324 | ||
| Injectables | 325 | ||
| Surgery | 325 | ||
| Brow | 325 | ||
| Periocular complex | 325 | ||
| Midface | 325 | ||
| Smile | 326 | ||
| Lower face | 326 | ||
| Neck | 326 | ||
| Complications and concerns | 329 | ||
| Summary | 329 | ||
| References | 329 | ||
| Evidence-Based Facial Fracture Management | 335 | ||
| Key points | 335 | ||
| Introduction | 335 | ||
| Antibiotics and facial fractures | 336 | ||
| Nasal fractures | 337 | ||
| Mandible fractures | 338 | ||
| Angle Fractures | 338 | ||
| Condylar and Subcondylar Fractures | 340 | ||
| Orbital Fractures | 341 | ||
| Midface Fractures | 342 | ||
| Skull Base Fractures | 343 | ||
| Future Directions | 343 | ||
| Summary | 343 | ||
| References | 344 | ||
| Microvascular Reconstruction | 347 | ||
| Key points | 347 | ||
| Introduction | 347 | ||
| Monitoring free tissue transfer | 348 | ||
| Clinical Monitoring Involving Evaluation of the Flap by Physical Examination | 348 | ||
| Lateral mandibular defect | 348 | ||
| Functional Outcomes in Reconstruction of the Oral Cavity and the Oropharynx | 350 | ||
| Methodology | 351 | ||
| Inclusion Criteria | 351 | ||
| Exclusions | 351 | ||
| Results | 351 | ||
| Discussion | 351 | ||
| Summary | 354 | ||
| References | 354 | ||
| Cleft Lip and Palate | 357 | ||
| Key points | 357 | ||
| Introduction | 357 | ||
| Cleft lip | 358 | ||
| Overview | 358 | ||
| Surgical Techniques | 359 | ||
| Unilateral cleft lip | 359 | ||
| Bilateral cleft lip | 360 | ||
| Timing | 360 | ||
| Other Therapeutic Options | 361 | ||
| Presurgical infant orthopedics and nasoalveolar molding | 361 | ||
| Lip adhesion | 361 | ||
| Alveolar bone grafting | 361 | ||
| Primary rhinoplasty | 361 | ||
| Postoperative nasal stents | 362 | ||
| Clinical Outcomes | 362 | ||
| Complications and Concerns | 362 | ||
| Wound complications | 362 | ||
| Maxillary growth | 363 | ||
| Cleft palate | 363 | ||
| Overview | 363 | ||
| Surgical Techniques | 363 | ||
| Timing | 364 | ||
| Speech | 364 | ||
| Facial growth | 365 | ||
| One-stage versus 2-stage (Schweckendiek) palate repair | 365 | ||
| Summary | 365 | ||
| Other Therapeutic Options | 366 | ||
| Tympanostomy tube placement | 366 | ||
| Clinical Outcomes | 366 | ||
| Complications and Concerns | 366 | ||
| Oronasal fistula | 366 | ||
| Velopharyngeal insufficiency | 366 | ||
| General therapeutic considerations for cleft lip and palate | 367 | ||
| Airway Concerns | 367 | ||
| Feeding | 368 | ||
| Arm Restraints | 368 | ||
| Relevant Pharmacology | 368 | ||
| Antibiotics | 368 | ||
| Steroids | 368 | ||
| Analgesia | 368 | ||
| Summary | 368 | ||
| References | 368 | ||
| Evidence-Based Medicine in the Treatment of Infantile Hemangiomas | 373 | ||
| Key points | 373 | ||
| Historical perspective and current classification scheme | 373 | ||
| Epidemiology and clinical presentation | 375 | ||
| Watch and wait | 377 | ||
| Steroids—systemic/intralesional | 377 | ||
| Propranolol | 378 | ||
| Topical/intralesional β-blockers | 381 | ||
| Surgery | 382 | ||
| Pulsed dye laser therapy | 382 | ||
| Multimodality | 388 | ||
| Summary | 388 | ||
| Acknowledgments | 388 | ||
| References | 388 | ||
| Early Practice Focus | 393 | ||
| Key points | 393 | ||
| Introduction/Overview of evidence-based medicine | 393 | ||
| Levels of evidence | 394 | ||
| Strength of recommendations | 394 | ||
| Resources for evidence-based medicine | 395 | ||
| Incorporating evidence-based medicine into practice | 395 | ||
| Outcome measures | 395 | ||
| Expert data collection | 396 | ||
| Facial Nerve Grading Systems | 396 | ||
| Scar-Assessment Scales | 398 | ||
| Patient-reported outcome measures | 398 | ||
| Aging Face and Facial Rejuvenation Assessment Scales | 401 | ||
| Data storage, research preparedness, and the Health Insurance Portability and Accountability Act | 402 | ||
| Barriers to evidence-based medicine | 403 | ||
| Summary | 403 | ||
| References | 403 | ||
| Index | 407 |